BioSpace News Archive

BioPharma Services, Inc. (BioPharma) is excited to announce the relocation of their US based clinical facility to a new location in the greater city of St. Louis, Missouri. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005065/en/ BioPharma’s new site in St. Louis MO The ongoing pandemic has compelled BioPharma to re-evaluate our clinical operations i

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US Patent

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“ MIS ”), is pleased to announce today that it has entered into definitive agreements with a single healthcare-foc

Company presentation will highlight progress towards transitioning to a fully integrated commercial stage company with an initial focus on vaginal yeast infection

In the initial scramble to quell the impact of the COVID-19 pandemic, the rapid antibody test market was been flooded. Not all tests are created equal and the COVID-19 crisis introduced the opportunity to try unproven players in rapid diagnostic testing.

Origami Therapeutics http://origamitherapeutics.com , an early stage biotech company taking a precision medicine approach to find disease-modifying treatments for neurodegenerative diseases caused by protein folding, announced today it has been selected as one of the 60 “Cool Companies” for 2020 by Connect with San Diego Venture Group. Ori

During a record fundraising year, the gaming community is celebrating $26.3 million raised since the inception of St. Jude PLAY LIVE, the video game fundraising program that supports the lifesaving mission of St. Jude Children’s Research Hospital: Finding cures.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, the research partner of ThermoGenesis’ joint venture, ImmuneCyte, Inc.,

The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online.

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new competition that will support cutting-edge research that could significantly improve diagnostic testing and patient care.